Your browser doesn't support javascript.
loading
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome.
Kim, Hawk; Lee, Je-Hwan; Lee, Won-Sik; Kim, Inho; Moon, Joon Ho; Choi, Chul Won; Lee, Ho Sup; Park, Jinny; Choi, Yunsuk; Shin, Ho-Jin; Cho, Su-Hee; Kim, Kyoung Ha; Kim, Sung-Yong; Kim, Yoo-Jin.
Afiliação
  • Kim H; Division of Haematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Lee JH; Department of Haematology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee WS; Division of Haematology/Oncology, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
  • Kim I; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Moon JH; Department of Haematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Choi CW; Division of Oncology and Haematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Lee HS; Division of Haematology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea.
  • Park J; Division of Haematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Choi Y; Division of Haematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Shin HJ; Division of Haematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Cho SH; Division of Haemato-oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
  • Kim KH; Department of Haematology/Oncology, Soonchunhyang University Hospital, Seoul, Korea.
  • Kim SY; Division of Haematology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Kim YJ; Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Br J Haematol ; 186(5): e151-e155, 2019 09.
Article em En | MEDLINE | ID: mdl-31177524
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Inibidores da Angiogênese / Lenalidomida Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Inibidores da Angiogênese / Lenalidomida Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2019 Tipo de documento: Article